BACKGROUND. Radiation therapy as an adjunct to surgery for rectal cancer has been shown to reduce local recurrence but has not improved survival. In a previous study, combined radiation and chemotherapy improved survival significantly as compared with surgery alone, but not as compared with adjuvant radiation, which many regard as standard therapy. We designed a combination regimen to optimize the contribution of chemotherapy, decrease recurrence, and improve survival as compared with adjuvant radiation alone. METHODS. Two hundred four patients with rectal carcinoma that was either deeply invasive or metastatic to regional lymph nodes were randomly assigned to postoperative radiation alone (4500 to 5040 cGy) or to radiation plus fluorouracil, which was both preceded and followed by a cycle of systemic therapy with fluorouracil plus semustine (methyl-CCNU). RESULTS. After a median follow-up of more than seven years, the combined therapy had reduced the recurrence of rectal cancer by 34 percent (P = 0.0016; 95 percent confidence interval, 12 to 50 percent). Initial local recurrence was reduced by 46 percent (P = 0.036; 95 percent confidence interval, 2 to 70 percent), and distant metastasis by 37 percent (P = 0.011; 95 percent confidence interval, 9 to 57 percent). In addition, combined therapy reduced the rate of cancer-related deaths by 36 percent (P = 0.0071; 95 percent confidence interval, 14 to 53 percent) and the overall death rate by 29 percent (P = 0.025; 95 percent confidence interval, 7 to 45 percent). Its acute toxic effects included nausea, vomiting, diarrhea, leukopenia, and thrombocytopenia. These effects were seldom severe. Severe, delayed treatment-related reactions, usually small-bowel obstruction requiring surgery, occurred in 6.7 percent of all patients receiving radiation, and the frequencies of these complications were comparable in both treatment groups. CONCLUSIONS. The combination of postoperative local therapy with radiation plus fluorouracil and systemic therapy with a fluorouracil-based regimen significantly and substantively improves the results of therapy for rectal carcinoma with a poor prognosis, as compared with postoperative radiation alone.
Source Information
Duluth Community Clinical Oncology Program, Minn.
This article has been cited by other articles:
Roh, M. S., Colangelo, L. H., O'Connell, M. J., Yothers, G., Deutsch, M., Allegra, C. J., Kahlenberg, M. S., Baez-Diaz, L., Ursiny, C. S., Petrelli, N. J., Wolmark, N.
(2009). Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03. JCO
27: 5124-5130
[Abstract][Full Text]
Carlomagno, C., Farella, A., Bucci, L., D'Armiento, F. P., Pesce, G., Pepe, S., Cannella, L., Pacelli, R., De Stefano, A., Solla, R., D'Armiento, M. R., De Placido, S.
(2009). Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study. Ann Oncol
20: 906-912
[Abstract][Full Text]
Braendengen, M., Tveit, K. M., Berglund, A., Birkemeyer, E., Frykholm, G., Pahlman, L., Wiig, J. N., Bystrom, P., Bujko, K., Glimelius, B.
(2008). Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer. JCO
26: 3687-3694
[Abstract][Full Text]
Casado, E., Pfeiffer, P., Feliu, J., Gonzalez-Baron, M., Vestermark, L., Jensen, H. A.
(2008). UFT (tegafur-uracil) in rectal cancer. Ann Oncol
19: 1371-1378
[Abstract][Full Text]
Morris, A. M., Billingsley, K. G., Hayanga, A. J., Matthews, B., Baldwin, L.-M., Birkmeyer, J. D.
(2008). Residual Treatment Disparities After Oncology Referral for Rectal Cancer. JNCI J Natl Cancer Inst
100: 738-744
[Abstract][Full Text]
Harrison, J. D., Solomon, M. J., Young, J. M., Meagher, A., Butow, P., Salkeld, G., Hruby, G., Clarke, S.
(2008). Patient and Physician Preferences for Surgical and Adjuvant Treatment Options for Rectal Cancer. Arch Surg
143: 389-394
[Abstract][Full Text]
Kachnic, L. A., Hong, T. S., Ryan, D. P.
(2008). Rectal Cancer at the Crossroads: The Dilemma of Clinically Staged T3, N0, M0 Disease. JCO
26: 350-351
[Full Text]
Willett, C. G., Czito, B. G., Bendell, J. C.
(2007). Radiation Therapy in Stage II and III Rectal Cancer. Clin. Cancer Res.
13: 6903s-6908s
[Abstract][Full Text]
Aschele, C., Lonardi, S.
(2007). Multidisciplinary treatment of rectal cancer: medical oncology.. Ann Oncol
18: 1908-1915
[Full Text]
Czito, B. G., Willett, C. G.
(2007). Commentary: Rectal Cancer An Evolution of Treatment. The Oncologist
12: 1319-1320
[Full Text]
Wolpin, B. M., Meyerhardt, J. A., Mamon, H. J., Mayer, R. J.
(2007). Adjuvant Treatment of Colorectal Cancer. CA Cancer J Clin
57: 168-185
[Abstract][Full Text]
Haddock, M. G., Sloan, J. A., Bollinger, J. W., Soori, G., Steen, P. D., Martenson, J. A.
(2007). Patient Assessment of Bowel Function During and After Pelvic Radiotherapy: Results of a Prospective Phase III North Central Cancer Treatment Group Clinical Trial. JCO
25: 1255-1259
[Abstract][Full Text]
Machiels, J-P, Sempoux, C, Scalliet, P, Coche, J-C, Humblet, Y, Van Cutsem, E, Kerger, J, Canon, J-L, Peeters, M, Aydin, S, Laurent, S, Kartheuser, A, Coster, B, Roels, S, Daisne, J-F, Honhon, B, Duck, L, Kirkove, C, Bonny, M-A, Haustermans, K
(2007). Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer. Ann Oncol
18: 738-744
[Abstract][Full Text]
Rodel, C., Liersch, T., Hermann, R. M., Arnold, D., Reese, T., Hipp, M., Furst, A., Schwella, N., Bieker, M., Hellmich, G., Ewald, H., Haier, J., Lordick, F., Flentje, M., Sulberg, H., Hohenberger, W., Sauer, R.
(2007). Multicenter Phase II Trial of Chemoradiation With Oxaliplatin for Rectal Cancer. JCO
25: 110-117
[Abstract][Full Text]
Gill, S., Blackstock, A. W., Goldberg, R. M.
(2007). Colorectal Cancer. Mayo Clin Proc.
82: 114-129
[Abstract][Full Text]
Han, N., Galandiuk, S.
(2006). Induction Chemoradiation for Rectal Cancer. Arch Surg
141: 1246-1252
[Abstract][Full Text]
Liersch, T., Langer, C., Ghadimi, B. M., Kulle, B., Aust, D. E., Baretton, G. B., Schwabe, W., Hausler, P., Becker, H., Jakob, C.
(2006). Lymph Node Status and TS Gene Expression Are Prognostic Markers in Stage II/III Rectal Cancer After Neoadjuvant Fluorouracil-Based Chemoradiotherapy. JCO
24: 4062-4068
[Abstract][Full Text]
Nissan, A., Stojadinovic, A., Shia, J., Hoos, A., Guillem, J. G., Klimstra, D., Cohen, A. M., Minsky, B. D., Paty, P. B., Wong, W. D.
(2006). Predictors of Recurrence in Patients With T2 and Early T3, N0 Adenocarcinoma of the Rectum Treated by Surgery Alone. JCO
24: 4078-4084
[Abstract][Full Text]
Smalley, S. R., Benedetti, J. K., Williamson, S. K., Robertson, J. M., Estes, N. C., Maher, T., Fisher, B., Rich, T. A., Martenson, J. A., Kugler, J. W., Benson, A. B. III, Haller, D. G., Mayer, R. J., Atkins, J. N., Cripps, C., Pedersen, J., Periman, P. O., Tanaka, M. S. Jr, Leichman, C. G., Macdonald, J. S.
(2006). Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144. JCO
24: 3542-3547
[Abstract][Full Text]
Glynne-Jones, R., Dunst, J., Sebag-Montefiore, D.
(2006). The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?. Ann Oncol
17: 361-371
[Abstract][Full Text]
De Paoli, A., Chiara, S., Luppi, G., Friso, M. L., Beretta, G. D., Del Prete, S., Pasetto, L., Santantonio, M., Sarti, E., Mantello, G., Innocente, R., Frustaci, S., Corvo, R., Rosso, R.
(2006). Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol
17: 246-251
[Abstract][Full Text]
Machiels, J.-P., Duck, L., Honhon, B., Coster, B., Coche, J.-C., Scalliet, P., Humblet, Y., Aydin, S., Kerger, J., Remouchamps, V., Canon, J.-L., Van Maele, P., Gilbeau, L., Laurent, S., Kirkove, C., Octave-Prignot, M., Baurain, J.-F., Kartheuser, A., Sempoux, C.
(2005). Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. Ann Oncol
16: 1898-1905
[Abstract][Full Text]
Kwon, H.-C., Moon, C. H., Kim, S.-H., Choi, H.-J., Lee, H.-S., Roh, M. S., Hwang, T.-H., Kim, J.-S., Kim, H.-J.
(2005). Expression of Double-stranded RNA-activated Protein kinase (PKR) and its Prognostic Significance in Lymph Node Negative Rectal Cancer. Jpn J Clin Oncol
35: 545-550
[Abstract][Full Text]
O'Connell, M. J.
(2005). Combined-Modality Neoadjuvant Therapy for Rectal Cancer. JCO
23: 5450-5451
[Full Text]
Bosset, J.-F., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., Daban, A., Bardet, E., Beny, A., Briffaux, A., Collette, L.
(2005). Enhanced Tumorocidal Effect of Chemotherapy With Preoperative Radiotherapy for Rectal Cancer: Preliminary Results--EORTC 22921. JCO
23: 5620-5627
[Abstract][Full Text]
Andre, N, Schmiegel, W
(2005). CHEMORADIOTHERAPY FOR COLORECTAL CANCER. Gut
54: 1194-1202
[Full Text]
Chau, I., Norman, A. R., Cunningham, D., Tait, D., Ross, P. J., Iveson, T., Hill, M., Hickish, T., Lofts, F., Jodrell, D., Webb, A., Oates, J. R.
(2005). A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Ann Oncol
16: 549-557
[Abstract][Full Text]
Hofheinz, R.-D., von Gerstenberg-Helldorf, B., Wenz, F., Gnad, U., Kraus-Tiefenbacher, U., Muldner, A., Hehlmann, R., Post, S., Hochhaus, A., Willeke, F.
(2005). Phase I Trial of Capecitabine and Weekly Irinotecan in Combination With Radiotherapy for Neoadjuvant Therapy of Rectal Cancer. JCO
23: 1350-1357
[Abstract][Full Text]
Sauer, R., Becker, H., Hohenberger, W., Rodel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., Karstens, J.-H., Liersch, T., Schmidberger, H., Raab, R., the German Rectal Cancer Study Group,
(2004). Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. NEJM
351: 1731-1740
[Abstract][Full Text]
Martenson, J. A. Jr, Willett, C. G., Sargent, D. J., Mailliard, J. A., Donohue, J. H., Gunderson, L. L., Thomas, C. R. Jr, Fisher, B., Benson, A. B. III, Myerson, R., Goldberg, R. M.
(2004). Phase III Study of Adjuvant Chemotherapy and Radiation Therapy Compared With Chemotherapy Alone in the Surgical Adjuvant Treatment of Colon Cancer: Results of Intergroup Protocol 0130. JCO
22: 3277-3283
[Abstract][Full Text]
Rich, T. A., Shepard, R. C., Mosley, S. T.
(2004). Four Decades of Continuing Innovation With Fluorouracil: Current and Future Approaches to Fluorouracil Chemoradiation Therapy. JCO
22: 2214-2232
[Abstract][Full Text]
Gunderson, L. L., Sargent, D. J., Tepper, J. E., Wolmark, N., O'Connell, M. J., Begovic, M., Allmer, C., Colangelo, L., Smalley, S. R., Haller, D. G., Martenson, J. A., Mayer, R. J., Rich, T. A., Ajani, J. A., MacDonald, J. S., Willett, C. G., Goldberg, R. M.
(2004). Impact of T and N Stage and Treatment on Survival and Relapse in Adjuvant Rectal Cancer: A Pooled Analysis. JCO
22: 1785-1796
[Abstract][Full Text]
Telford, J. J., Saltzman, J. R., Kuntz, K. M., Syngal, S.
(2004). Impact of Preoperative Staging and Chemoradiation Versus Postoperative Chemoradiation on Outcome in Patients With Rectal Cancer: A Decision Analysis. JNCI J Natl Cancer Inst
96: 191-201
[Abstract][Full Text]
Simunovic, M., Gafni, A., Levine, M.
(2004). Economics of Preoperative Radiotherapy With Total Mesorectal Excision: What Can We Learn From the Dutch Experience?. JCO
22: 217-219
[Full Text]
Hodgson, D. C., Zhang, W., Zaslavsky, A. M., Fuchs, C. S., Wright, W. E., Ayanian, J. Z.
(2003). Relation of Hospital Volume to Colostomy Rates and Survival for Patients With Rectal Cancer. JNCI J Natl Cancer Inst
95: 708-716
[Abstract][Full Text]
Loprinzi, C. L., Martenson, J. A.
(2003). Keratinocyte Growth Factor: Not Yet Ready for Prime Time. JCO
21: 1429-1430
[Full Text]
Ito, Y., Ohtsu, A., Ishikura, S., Boku, N., Nihei, K., Ogino, T., Ikeda, H.
(2003). Efficacy of Chemoradiotherapy on Pain Relief in Patients with Intrapelvic Recurrence of Rectal Cancer. Jpn J Clin Oncol
33: 180-185
[Abstract][Full Text]
James, R. D., Botwood, N., Vernon, C. C., Price, P.
(2003). Raltitrexed plus radiotherapy for the treatment of unresectable/recurrent rectal cancer: a phase I study. Ann Oncol
14: 570-573
[Abstract][Full Text]
Ayanian, J. Z., Zaslavsky, A. M., Fuchs, C. S., Guadagnoli, E., Creech, C. M., Cress, R. D., O'Connor, L. C., West, D. W., Allen, M. E., Wolf, R. E., Wright, W. E.
(2003). Use of Adjuvant Chemotherapy and Radiation Therapy for Colorectal Cancer in a Population-Based Cohort. JCO
21: 1293-1300
[Abstract][Full Text]
Gennatas, C., Dardoufas, C., Mouratidou, D., Tsavaris, N., Pouli, A., Androulakis, G., Philippakis, M., Voros, D., Batalis, T., Besbeas, S., Hatzistylianos, G., Katsos, J., Komporozos, V., Legakis, N., Mallas, H., Peros, G., Photopoulos, A., Pisiotis, C., Polymeneas, G., Retalis, G., Samanidis, L., Smyrniotis, V., Stamatiadis, A., Vasiliou, J., Andreadis, H., Papadimitriou, J.
(2003). Surgical adjuvant therapy of rectal carcinoma: a controlled evaluation of leucovorin, 5-fluorouracil and radiation therapy with or without interferon-{alpha}2b. Ann Oncol
14: 378-382
[Abstract][Full Text]
Ammann, K., Kirchmayr, W., Klaus, A., Muhlmann, G., Kafka, R., Oberwalder, M., De Vries, A., Ofner, D., Weiss, H.
(2003). Impact of Neoadjuvant Chemoradiation on Anal Sphincter Function in Patients With Carcinoma of the Midrectum and Low Rectum. Arch Surg
138: 257-261
[Abstract][Full Text]
Dorudi, S., Steele, R. J., McArdle, C. S
(2002). Surgery for colorectal cancer. Br Med Bull
64: 101-118
[Abstract][Full Text]
Glimelius, B.
(2002). Radiotherapy in rectal cancer. Br Med Bull
64: 141-157
[Abstract][Full Text]
Dunst, J., Reese, T., Sutter, T., Zuhlke, H., Hinke, A., Kolling-Schlebusch, K., Frings, S.
(2002). Phase I Trial Evaluating the Concurrent Combination of Radiotherapy and Capecitabine in Rectal Cancer. JCO
20: 3983-3991
[Abstract][Full Text]
Lefere, P. A., Gryspeerdt, S. S., Dewyspelaere, J., Baekelandt, M., Van Holsbeeck, B. G.
(2002). Dietary Fecal Tagging as a Cleansing Method before CT Colonography: Initial Results—Polyp Detection and Patient Acceptance. Radiology
224: 393-403
[Abstract][Full Text]
Allegra, C. J., Parr, A. L., Wold, L. E., Mahoney, M. R., Sargent, D. J., Johnston, P., Klein, P., Behan, K., O'Connell, M. J., Levitt, R., Kugler, J. W., Tria Tirona, M., Goldberg, R. M.
(2002). Investigation of the Prognostic and Predictive Value of Thymidylate Synthase, p53, and Ki-67 in Patients With Locally Advanced Colon Cancer. JCO
20: 1735-1743
[Abstract][Full Text]
Lee, J.-H., Lee, J.-H., Ahn, J.-H., Bahng, H., Kim, T.-W., Kang, Y.-K., Lee, K.-H., Kim, J.-C., Yu, C.-S., Kim, J.-H., Ahn, S.-D., Kim, W.-K., Kim, S.-H., Lee, J.-S.
(2002). Randomized Trial of Postoperative Adjuvant Therapy in Stage II and III Rectal Cancer to Define the Optimal Sequence of Chemotherapy and Radiotherapy: A Preliminary Report. JCO
20: 1751-1758
[Abstract][Full Text]
Potosky, A. L., Harlan, L. C., Kaplan, R. S., Johnson, K. A., Lynch, C. F.
(2002). Age, Sex, and Racial Differences in the Use of Standard Adjuvant Therapy for Colorectal Cancer. JCO
20: 1192-1202
[Abstract][Full Text]
Lawes, D, Boulos, P B
(2002). Advances in the management of rectal cancer. JRSM
95: 587-590
[Full Text]
Stocchi, L., Nelson, H., Sargent, D. J., O'Connell, M. J., Tepper, J. E., Krook, J. E., Beart, R. Jr
(2001). Impact of Surgical and Pathologic Variables in Rectal Cancer: A United States Community and Cooperative Group Report. JCO
19: 3895-3902
[Abstract][Full Text]
Schrag, D., Gelfand, S. E., Bach, P. B., Guillem, J., Minsky, B. D., Begg, C. B.
(2001). Who Gets Adjuvant Treatment for Stage II and III Rectal Cancer? Insight From Surveillance, Epidemiology, and End Results-Medicare. JCO
19: 3712-3718
[Abstract][Full Text]
Glynne-Jones, R., Debus, J.
(2001). Improving Chemoradiotherapy in Rectal Cancer. The Oncologist
6: 29-34
[Abstract][Full Text]
Freyer, G., Bossard, N., Romestaing, P., Mornex, F., Chapet, O., Trillet-Lenoir, V., Gerard, J.-P.
(2001). Addition of Oxaliplatin to Continuous Fluorouracil, L-Folinic Acid, and Concomitant Radiotherapy in Rectal Cancer: The Lyon R 97-03 Phase I Trial. JCO
19: 2433-2438
[Abstract][Full Text]
Kelsen, D.
(2001). Preoperative Chemoradiotherapy for Esophageal Cancer. JCO
19: 283-285
[Full Text]
Hoff, P. M., Janjan, N., Saad, E. D., Skibber, J., Crane, C., Lassere, Y., Cleary, K. R., Benner, S., Randolph, J., Abbruzzese, J. L., Pazdur, R.
(2000). Phase I Study of Preoperative Oral Uracil and Tegafur Plus Leucovorin and Radiation Therapy in Rectal Cancer. JCO
18: 3529-3534
[Abstract][Full Text]
Lammering, G., Taher, M. M., Gruenagel, H.-H., Borchard, F., Porschen, R.
(2000). Alteration of DNA Ploidy Status and Cell Proliferation Induced by Preoperative Radiotherapy Is a Prognostic Factor in Rectal Cancer. Clin. Cancer Res.
6: 3215-3221
[Abstract][Full Text]
Edler, D., Hallström, M., Johnston, P. G., Magnusson, I., Ragnhammar, P., Blomgren, H.
(2000). Thymidylate Synthase Expression: An Independent Prognostic Factor for Local Recurrence, Distant Metastasis, Disease-free and Overall Survival in Rectal Cancer. Clin. Cancer Res.
6: 1378-1384
[Abstract][Full Text]
Martenson, J. A., Bollinger, J. W., Sloan, J. A., Novotny, P. J., Urias, R. E., Michalak, J. C., Shanahan, T. G., Mailliard, J. A., Levitt, R.
(2000). Sucralfate in the Prevention of Treatment-Induced Diarrhea in Patients Receiving Pelvic Radiation Therapy: A North Central Cancer Treatment Group Phase III Double-Blind Placebo-Controlled Trial. JCO
18: 1239-1245
[Abstract][Full Text]
Wolmark, N., Wieand, H. S., Hyams, D. M., Colangelo, L., Dimitrov, N. V., Romond, E. H., Wexler, M., Prager, D., Cruz, A. B. Jr., Gordon, P. H., Petrelli, N. J., Deutsch, M., Mamounas, E., Wickerham, D. L., Fisher, E. R., Rockette, H., Fisher, B.
(2000). Randomized Trial of Postoperative Adjuvant Chemotherapy With or Without Radiotherapy for Carcinoma of the Rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. JNCI J Natl Cancer Inst
92: 388-396
[Abstract][Full Text]
Hwang, H.-S., Davis, T. W., Houghton, J. A., Kinsella, T. J.
(2000). Radiosensitivity of Thymidylate Synthase-deficient Human Tumor Cells Is Affected by Progression through the G1 Restriction Point into S-Phase: Implications for Fluoropyrimidine Radiosensitization. Cancer Res.
60: 92-100
[Abstract][Full Text]
Cagir, B., Gelmann, A., Park, J., Fava, T., Tankelevitch, A., Bittner, E. W., Weaver, E. J., Palazzo, J. P., Weinberg, D., Fry, R. D., Waldman, S. A.
(1999). Guanylyl Cyclase C Messenger RNA Is a Biomarker for Recurrent Stage II Colorectal Cancer. ANN INTERN MED
131: 805-812
[Abstract][Full Text]
TORTOLANI, P. J., KAUFMAN, H. S., NAHABEDIAN, M. Y., FRASSICA, F. J.
(1999). Pericapsular Fistula of the Hip After Radiation Therapy and Resection of a Rectal Carcinoma. A Case Report. JBJS
81: 1596-9
[Full Text]
Halling, K. C., French, A. J., McDonnell, S. K., Burgart, L. J., Schaid, D. J., Peterson, B. J., Moon-Tasson, L., Mahoney, M. R., Sargent, D. J., O'Connell, M. J., Witzig, T. E., Farr, G. H. Jr., Goldberg, R. M., Thibodeau, S. N.
(1999). Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal Cancers. JNCI J Natl Cancer Inst
91: 1295-1303
[Abstract][Full Text]
Francois, Y., Nemoz, C. J., Baulieux, J., Vignal, J., Grandjean, J.-P., Partensky, C., Souquet, J. C., Adeleine, P., Gerard, J.-P.
(1999). Influence of the Interval Between Preoperative Radiation Therapy and Surgery on Downstaging and on the Rate of Sphincter-Sparing Surgery for Rectal Cancer: The Lyon R90-01 Randomized Trial. JCO
17: 2396-2396
[Abstract][Full Text]
Varma, M. G., Rogers, S. J., Schrock, T. R., Welton, M. L.
(1999). Local Excision of Rectal Carcinoma. Arch Surg
134: 863-868
[Abstract][Full Text]
Wexner, S. D.
(1999). Invited Critique: Whole-Body PET Imaging With [18F]Fluorodeoxyglucose in Management of Recurrent Colorectal Cancer. Arch Surg
134: 511-513
[Full Text]
Lavery, I. C., Fazio, V. W., Lopez-Kostner, F., Vikram, B., Heriot, A. G., Cornes, P., Glees, J. P., Kumar, D., Pahlman, L., Glimelius, B., The Swedish Rectal Cancer Trial Group,
(1997). Radiotherapy for Rectal Cancer. NEJM
337: 346-348
[Full Text]
Swedish Rectal Cancer Trial,
(1997). Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer. NEJM
336: 980-987
[Abstract][Full Text]
Minsky, B. D.
(1997). Adjuvant Therapy for Rectal Cancer -- A Good First Step. NEJM
336: 1016-1017
[Full Text]
Stryker, S. J., Kiel, K. D., Rademaker, A., Shaw, J. M., Ujiki, G. T., Poticha, S. M.
(1996). Preoperative 'Chemoradiation' for Stages II and III Rectal Carcinoma. Arch Surg
131: 514-519
[Abstract]
Slevin, M. L
(1996). Adjuvant treatment for colorectal cancer. BMJ
312: 392-393
[Full Text]
Saltz, L. B., Kemeny, N. E.
(1996). Adjuvant Chemotherapy of Colorectal Cancer. The Oncologist
1: 22-29
[Abstract][Full Text]
Wayne, M. S., Cath, A., Pamies, R. J.
(1995). Colorectal Cancer: A Practical Review for the Primary Care Physician. Arch Fam Med
4: 357-366
[Abstract]
Lichter, A. S., Lawrence, T. S.
(1995). Recent Advances in Radiation Oncology. NEJM
332: 371-379
[Full Text]
O'Connell, M. J., Martenson, J. A., Wieand, H. S., Krook, J. E., Macdonald, J. S., Haller, D. G., Mayer, R. J., Gunderson, L. L., Rich, T. A.
(1994). Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative Surgery. NEJM
331: 502-507
[Abstract][Full Text]
Jen, J., Kim, H., Piantadosi, S., Liu, Z.-F., Levitt, R. C., Sistonen, P., Kinzler, K. W., Vogelstein, B., Hamilton, S. R.
(1994). Allelic Loss of Chromosome 18q and Prognosis in Colorectal Cancer. NEJM
331: 213-221
[Abstract][Full Text]
Moertel, C. G.
(1994). Chemotherapy for Colorectal Cancer. NEJM
330: 1136-1142
[Full Text]
Welch, J. P., Welch, C. E.
(1993). Cancer of the Rectum: Where Are We? Where Are We Going?. Arch Surg
128: 697-702
[Abstract]
Marks, G., Mohiuddin, M., Eitan, A., Masoni, L., Rakinic, J.
(1991). High-Dose Preoperative Radiation and Radical Sphincter-Preserving Surgery for Rectal Cancer. Arch Surg
126: 1534-1540
[Abstract]
Ihde, D. C.
(1991). Chemotherapy Combined with Chest Irradiation for Locally Advanced Non-Small Cell Lung Cancer: The End of the Beginning?. ANN INTERN MED
115: 737-739
[Abstract]
(1991). ADJUVANT RADIOCHEMOTHERAPY IMPROVES OUTCOMES IN ADVANCED RECTAL CANCER. JWatch General
1991: 2-2
[Full Text]
